MENU
+Compare
LXEO
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$3.88
Change
+$0.61 (+18.65%)
Capitalization
128.78M

LXEO Lexeo Therapeutics Forecast, Technical & Fundamental Analysis

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LXEO with price predictions
Jun 06, 2025

LXEO in upward trend: price rose above 50-day moving average on June 04, 2025

LXEO moved above its 50-day moving average on June 04, 2025 date and that indicates a change from a downward trend to an upward trend. In of 14 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on LXEO as a result. In of 24 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LXEO just turned positive on June 05, 2025. Looking at past instances where LXEO's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where LXEO advanced for three days, in of 102 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 27 cases where LXEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LXEO moved out of overbought territory on May 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for LXEO crossed bearishly below the 50-day moving average on May 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LXEO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LXEO broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LXEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.462) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (59.923). LXEO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (260.036).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LXEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LXEO is expected to report earnings to fall 8.08% to -91 cents per share on August 18

Lexeo Therapeutics LXEO Stock Earnings Reports
Q2'25
Est.
$-0.91
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.13
The last earnings report on May 13 showed earnings per share of -99 cents, missing the estimate of -88 cents. With 1.93M shares outstanding, the current market capitalization sits at 128.78M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCIGX19.91N/A
N/A
Gabelli International Growth C
MITGX32.23N/A
N/A
MFS Massachusetts Investors Tr R1
LMREX31.87N/A
N/A
ClearBridge Mid Cap R
SSEAX12.62N/A
N/A
SEI Screened World Equity Ex-US A (SIIT)
GLVNX78.72N/A
N/A
Invesco Global Focus R

LXEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+18.65%
ARWR - LXEO
50%
Loosely correlated
+2.13%
COGT - LXEO
45%
Loosely correlated
+13.52%
VERV - LXEO
43%
Loosely correlated
+8.12%
KOD - LXEO
42%
Loosely correlated
+7.65%
BEAM - LXEO
42%
Loosely correlated
+9.26%
More